Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants

Clinical trial NCT07352423 · RECRUITING

Trial details

NCT number: NCT07352423
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2026-03-26
Primary completion: 2026-12-23
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.